JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Kulicke & Soffa
KLIC
$5.01B
| $7.61M | ﹤0.01% |
337,727
-50,986
| -13% | -$1.12M |
|
|
FINV
2227
FinVolution Group
FINV
$1.07B
| $7.59M | ﹤0.01% |
1,781,366
+1,295,462
| +267% | +$6.38M |
|
2228
Baker Hughes
BKR
$63B
| $7.57M | ﹤0.01% |
306,406
+9,531
| +3% | +$230K |
|
2229
Teradata
TDC
$2.57B
| $7.55M | ﹤0.01% |
212,622
+7,651
| +4% | +$298K |
|
2230
Medpace
MEDP
$16.2B
| $7.54M | ﹤0.01% |
117,611
-3,716
| -3% | -$214K |
|
2231
The Bancorp
TBBK
$2.82B
| $7.54M | ﹤0.01% |
838,708
-13,230
| -2% | -$122K |
|
|
CATM
2232
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $7.54M | ﹤0.01% |
281,131
-69,786
| -20% | -$2.27M |
|
2233
Advanced Energy
AEIS
$13.2B
| $7.54M | ﹤0.01% |
133,574
-10,490
| -7% | -$562K |
|
|
PFC
2234
DELISTED
Premier Financial Corp. Common Stock
PFC
| $7.52M | ﹤0.01% |
268,877
+12,303
| +5% | +$352K |
|
|
DRNA
2235
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.52M | ﹤0.01% |
477,324
+31,602
| +7% | +$430K |
|
2236
Golar LNG
GLNG
$5.21B
| $7.52M | ﹤0.01% |
426,878
+125,832
| +42% | +$2.39M |
|
2237
CALL
Takeda Pharmaceutical
TAK
$55.5B
| $7.51M | ﹤0.01% |
427,550
| – | – |
|
|
JOYY
2238
PUT
JOYY Inc
JOYY
$3.64B
| $7.49M | ﹤0.01% |
108,500
+7,000
| +7% | +$534K |
|
2239
Bank OZK
OZK
$5.7B
| $7.49M | ﹤0.01% |
255,046
-11,454
| -4% | -$355K |
|
2240
NovoCure
NVCR
$2.02B
| $7.49M | ﹤0.01% |
123,010
+49,395
| +67% | +$2.5M |
|
2241
PUT
Dominion Energy
D
$60.3B
| $7.47M | ﹤0.01% |
97,400
| – | – |
|
2242
Ericsson
ERIC
$33.6B
| $7.44M | ﹤0.01% |
776,244
+447,981
| +136% | +$4.34M |
|
2243
XPO
XPO
$24.7B
| $7.43M | ﹤0.01% |
390,000
-120,215
| -24% | -$2.45M |
|
2244
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $7.39M | ﹤0.01% |
301,010
-60,279
| -17% | -$1.57M |
|
2245
VSE Corp
VSEC
$6.48B
| $7.38M | ﹤0.01% |
263,722
-7,307
| -3% | -$210K |
|
2246
PUT
Wayfair
W
$13.9B
| $7.38M | ﹤0.01% |
+50,000
| New | +$7.52M |
|
|
DNR
2247
DELISTED
Denbury Resources, Inc.
DNR
| $7.38M | ﹤0.01% |
5,809,926
-2,137,271
| -27% | -$3.88M |
|
2248
O-I Glass
OI
$1.05B
| $7.37M | ﹤0.01% |
441,246
+58,195
| +15% | +$1.04M |
|
2249
CALL
Chubb
CB
$133B
| $7.36M | ﹤0.01% |
+50,000
| New | +$7.22M |
|
|
2250
PUT
Chubb
CB
$133B
| $7.36M | ﹤0.01% |
+50,000
| New | +$7.22M |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.